Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
if what i've heard is true, all longs here will be very pleased.
agreed. over 60 reservations with deployments in progress. exciting times!
getting juicy in here. news must be close with how they're trading these blocks around.
or the friendly note holder really is friendly in the sense they're clearing the shares before takeoff...
CDEL and MAXM need to get a room and get it over with so we can all move on.
CDEL can't get enough...
accumulation line moving up, confirming what we're all seeing from MAXM combined with the retail buying strength.
i doubt it. good question though.
if this merger was in doubt, would omvs still be releasing RAD's news?
RAD has a lot on the line here in terms of building a reputation and a business.
screw it, i hope maxm hangs around next week too. a few down days to be able to add even more than i would have already sounds good to me.
The partnership with Romeo is a really big freaking deal...
this stock is on the move
omvs is on the move.
I'm not sure people are realizing how big Romeo Power is...
The guy who designed the SpaceX rockets is in charge of the engineering team here. They have contracts with Ford and Chrysler among others.
more news today on Romeo
https://electrek.co/2017/08/24/factory-ev-batteries-engineer-spacexs-falcon-and-dragon-battery-packs/
"Serial entrepreneur Michael Patterson, Romeo Power founder, and CEO, is leading the company, but the engineering team is led by Harris who is credited as lead designer of several world-class battery packs, like for SpaceX’s Falcon 9 Rocket Batteries, Cargo Dragon Spacecraft Batteries and for Crew Dragon Spacecraft Batteries."
Any guesses why RAD was singled out in today's massive news release for what is obviously a monster startup?
https://techcrunch.com/2017/08/24/with-bold-claims-about-its-battery-power-romeo-power-closes-on-30-million-in-seed-funding/
"According to Patterson, Romeo has booked $65 million in manufacturing contracts with its 15 customers, including five automotive companies — two of which are among the “big three” in Detroit, he says, referring to Ford, General Motors and Fiat Chrysler."
and yet it's RAD that was mentioned in today's PR. wow!
Since Romeo Power kicked off sales in 2017, the company has seen $65 million in initial orders scheduled for delivery in 2018. Current contracts and design agreements for the company span U.S. and European automakers, manufacturers of motorcycles and forklifts, industrial players such as Power Designers, robotics companies including Robotic Assistance Devices, and more.
dizzying day. Huge blocks getting bought, VERT bidding, MAXM selling.
this dude knows how to pump a stock
going green shortly
MAXM is down to .60.
just a little morning dilution today.
any bets on how much money gets traded at the end of the day?
omvs is on the move
you should google why companies go public. pretty basic stuff here.
we're going to need to hear something about this trial soon. so far they've been touting the 3 completed patients for quite some time. is #4 in the pipeline?
-get kistler's name off the otcmarkets page
-show that the trial is actually progressing. we've learning zip about prolanta for months now. that's all good, but constantly referencing the same number of completed patients after all of this time having passed is not very comforting.
perhaps it's all part of the great plan once the name is changed, we'll see.
Why haven't they still updated the otc markets page?
https://www.otcmarkets.com/stock/AEPP/profile
i've told the company repeatedly over the months that this page not being updated is bad news and explained some of the ramifications of leaving ends untied. i've never gotten a response about it.
the only two conclusions i can come up with are 1. they are idiots or 2. kistler actually still is involved in some way.
anybody else have a guess?
in a year when oncolix has prolanta humming along in the next phase, things are going to look very different.
it would be nice to hear that they've completed more than the three patients in their trial. that's the same number that's been reported the whole time. slow going here, but lots going on.
shady PR. super secret partner and of course a delay. hmm
this stock is on the move
agree, don't expect much news. these guys have done everything BUT pump this stock up.
lol.
this is so bizarre.
Section 4.3 Capitalization.
https://www.sec.gov/Archives/edgar/data/1584137/000147793217003504/aepp_ex21.htm
(a) As of the date hereof, the authorized capital stock of AEPP consists of: (i) 500,000,000 shares of AEPP Common Stock, of which 93,231,633 shares are issued outstanding; and (ii) 100,000,000 shares of “blank check” AEPP Preferred Stock, of which 100,000,000 are designated “Series A Preferred Stock,” none of which are issued and outstanding. The authorized capital stock of Merger Sub consists of 1,000 shares of Merger Sub Common Stock, of which 1,000 shares are issued and outstanding, all of which are owned by AEPP. All of the outstanding shares of AEPP capital stock and Merger Sub capital stock have been duly authorized and validly issued and are fully paid and nonassessable. All of the outstanding shares of AEPP capital stock and Merger Sub capital stock have been duly and validly issued in compliance with the AEPP Documents and Merger Sub Documents, as the case may be, and all applicable federal and state Securities Laws and other applicable Legal Requirements and all requirements set forth in the applicable AEPP Documents, and are owned, beneficially and of record, by those stockholders set forth on the most recent stockholders list held by AEPP’s transfer agent.
(b) At the Effective Time: (i) AEPP will have a total of 103,536,703 shares of its Common Stock that are issued and outstanding (61,465,130 shares of AEPP Common Stock owned by Oncolix will be cancelled and become AEPP treasury shares) and 62,138,680 shares of AEPP Preferred Stock issued and outstanding; (ii) 62,138,680 shares of common stock will be reserved for issuance upon conversion of 62,138,680 shares of AEPP Preferred Stock; (iii) 14,000,000 shares of AEPP Preferred Stock will be reserved for issuance pursuant to a contractual right to acquire 14,000,000 shares of AEPP Preferred Stock in exchange for future services; (iv) 14,000,000 shares of common stock will be reserved for issuance upon conversion of 14,000,000 shares of AEPP Preferred Stock; (v) 52,077,380 shares of AEPP Preferred Stock will be reserved for issuance upon exercise of warrants to purchase 52,077,380 shares of AEPP Preferred Stock; (vi) 52,077,380 shares of common stock will be reserved for issuance upon conversion of 52,077,380 shares of AEPP Preferred Stock; (vii) 7,000,000 shares of common stock will be reserved for issuance upon exercise of options to purchase 7,000,000 shares of AEPP Common Stock; (viii) 22,708,280 shares of common stock will be reserved for issuance upon exercise of warrants to purchase 22,708,280 shares of AEPP Common Stock, including warrants that may be issued prior to the closing;and (ix) 21,074,940 shares of common stock will be reserved for issuance upon conversion of convertible notes into shares of AEPP Common Stock. In addition, at or immediately after the Effective Time, AEPP will reserve such additional shares of AEPP Common Stock for (i) the conversion of debt issued subsequent to the date hereof and until the Effective Time, (ii) the exercise of options to acquire Oncolix Common Stock issued in connection with such additional convertible debt, (iii) adjustments to the conversion price of the existing Oncolix convertible debt based on the market price of AEPP Common Stock at the Effective Time (iv) anti-dilution adjustments to the conversion price of AEPP Preferred Stock and (v) accrued interest on convertible notes.
(c) Except as set forth in the AEPP Current SEC Reports or as described in 4.3(b) above, there are no: (i) outstanding subscriptions, options, calls, warrants, rights or agreements (whether or not currently exercisable) to acquire any shares of capital stock or other securities of AEPP or Merger Sub; (ii) outstanding securities, notes, instruments or obligations that are or may become convertible into or exchangeable for any shares of capital stock or other securities of AEPP or Merger Sub; (iii) outstanding or authorized stock appreciation, phantom stock or similar rights with respect to the capital stock of AEPP or Merger Sub; (iv) contracts under which AEPP or Merger Sub is or may become obligated to sell, transfer, exchange or issue any shares of capital stock or any other securities; or (v) agreements, voting trusts, proxies or understandings with respect to the voting, or registration under the Securities Act, of any shares of capital stock of AEPP or Merger Sub.
uhhh....
the other shares are what's call the float. this might be helpful
http://www.investopedia.com/ask/answers/04/091004.asp
i'm not sure why you're scared of the truth. it clearly said in the merger agreement that some 20M shares could be coming any minute as a note matures.
it's not a big deal, but imo denying what's in front of you is what really scares traders away. so a few shares are hitting the market, and with low volume and retail selling, the price will drop. that's pretty basic.
however, as i've pointed out a dozen other times, 20M more shares is nothing in the long run in regard to value of this company. Even 200M more shares would be nothing if Prolanta gets through Phase I successfully. Or even before that really, once AEPP is Oncolix, there could be tens or hundreds of millions in value there.
again, if you hide the facts, when things go crazy it's a lot easier to believe the nonsense. keep folks informed of the truth as we know it and it will make for healthier trading.
all IMO FWIW
if you dispute his post in any way, i'd love to see your reasoning. is there something we've missed that you can add for us?
they told us in last release that some shares would be coming at any minute. nobody should be surprised to see some dilution here.
oncolix has been very transparent about this process.
as i pointed out to the company, even with all of the outstanding notes fully diluted, the market cap of oncolix is significantly lower at current prices than it should be provided that prolanta really is showing positive results.
the question the bashers should be asking isn't some nonsense about kistler who is long gone. it should be about prolanta and if it works. if i was bashing, i'd form my argument with something like "prolanta doesn't work so the company is going to steal all of the money it can from you right now!"
of course that's likely untrue, but it makes more sense to me, IMO, than constantly referring to a man who is no longer affiliated with the company.
This is legit folks. lots of people are going to be learning about onconlix over the next weeks.
WHERE CAN I HEAR THE SHOW?
We can be heard all over the great State of Texas on the following stations / times:
KPRC AM950 Houston - 6PM Saturdays
NewsRadio KLBJ, 590AM and 99.7FM - 6AM Central Sundays
News Radio 1200 WOAI San Antonio - 10AM Central Sundays
NewsRadio 740 KTRH Houston - 11AM Central Sundays
NewsRadio 1080 KRLD Dallas / Fort Worth - 8PM Central Sundays
iHeartRadio - 6PM Saturdays KPRC, 10AM Sundays WOAI, 11AM Sundays KTRH
iTunes - On Demandj